Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Jul 14, 2022

BUY
$1.06 - $2.1 $212 - $420
200 New
200 $0
Q4 2021

Jan 21, 2022

SELL
$2.05 - $3.2 $204 - $320
-100 Closed
0 $0
Q2 2021

Jul 15, 2021

SELL
$2.57 - $4.85 $22,436 - $42,340
-8,730 Reduced 98.87%
100 $0
Q1 2021

Apr 14, 2021

BUY
$1.9 - $2.82 $16,777 - $24,900
8,830 New
8,830 $22,000

Others Institutions Holding VSTM

About Verastem, Inc.


  • Ticker VSTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 210,000,000
  • Market Cap $838M
  • Description
  • Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...
More about VSTM
Track This Portfolio

Track Global Retirement Partners, LLC Portfolio

Follow Global Retirement Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Retirement Partners, LLC with notifications on news.